Business Context and Reporting Period
Company: Retractable Technologies, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 21, 2009
Event Date: August 21, 2009 (Earliest event reported)
Business Context: The Company manufactures safety-engineered medical devices, specifically syringes.
Key Financial Metrics
This filing is a Current Report (Form 8-K) regarding a specific corporate event and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The Company announced the award of a new contract by the Department of Health and Human Services (HHS). The contract involves supplying a portion of the safety-engineered syringes required for the United States' vaccination efforts against the H1N1 virus (swine flu).
Guidance, Outlook, and Risks
- Program Duration: The H1N1 vaccination program is expected to run through March 2010.
- Financial Impact: The impact on the Company is currently uncertain and depends on the timing and quantities of H1N1 vaccine available for US use.
- Outlook: Management anticipates that the related unit sales increase could be material.
- Risks: The primary contingency is the availability of the H1N1 vaccine itself, which dictates the volume of syringes required.
Key Facts for Investor Verification
- Confirmation of the specific contract value or volume commitments from the Department of Health and Human Services.
- Updates on the actual availability and distribution timeline of the H1N1 vaccine in the US.
- Future earnings reports to quantify the actual revenue contribution from this contract.
- Any potential supply chain constraints the Company may face in meeting the anticipated material increase in unit sales.